ロード中...
Primaquine in vivax malaria: an update and review on management issues
Primaquine was officially licensed as an anti-malarial drug by the FDA in 1952. It has remained the only FDA licensed drug capable of clearing the intra-hepatic schizonts and hypnozoites of Plasmodium vivax. This update and review focuses on five major aspects of primaquine use in treatment of vivax...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3306765/ https://ncbi.nlm.nih.gov/pubmed/22152065 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-10-351 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|